GridAI Technologies Corp. (GRDX)
GRDX Stock Price Chart
Explore GridAI Technologies Corp. interactive price chart. Choose custom timeframes to analyze GRDX price movements and trends.
GRDX Company Profile
Discover essential business fundamentals and corporate details for GridAI Technologies Corp. (GRDX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
11 Oct 2016
Employees
2.00
Website
https://www.grid-ai.comCEO
Jason David Sawyer
Description
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
GRDX Financial Timeline
Browse a chronological timeline of GridAI Technologies Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 17 Aug 2026
EPS estimate is -$9.45k, while revenue estimate is $38.21k.
Earnings released on 27 May 2026
EPS came in at -$0.82 surpassing the estimated -$11.34k by +99.99%, while revenue for the quarter reached $38.21k , meeting expectations.
Earnings released on 25 Feb 2026
EPS came in at -$2.92 surpassing the estimated -$11.34k by +99.97%, while revenue for the quarter reached $36.25k , meeting expectations.
Earnings released on 19 Nov 2025
EPS came in at -$0.64 .
Stock split effective on 18 Aug 2025
Shares were split 1 : 3 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2025
EPS came in at -$0.14 .
Earnings released on 15 May 2025
EPS came in at -$0.63 .
Earnings released on 4 Apr 2025
EPS came in at -$2.61 falling short of the estimated -$0.41 by -536.59%.
Earnings released on 13 Nov 2024
EPS came in at -$1.32 falling short of the estimated -$0.96 by -37.50%.
Earnings released on 26 Aug 2024
EPS came in at -$3.84 falling short of the estimated -$1.55 by -147.68%.
Earnings released on 14 May 2024
EPS came in at $0.38 surpassing the estimated -$2.43 by +115.64%.
Earnings released on 27 Feb 2024
EPS came in at -$5.35 falling short of the estimated -$4.03 by -32.75%.
Stock split effective on 18 Dec 2023
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Sept 2023
EPS came in at -$9.08 surpassing the estimated -$33.60 by +72.98%.
Earnings released on 30 Jun 2023
EPS came in at -$36.89 falling short of the estimated -$20.80 by -77.38%.
Earnings released on 31 Mar 2023
EPS came in at -$35.70 surpassing the estimated -$43.90 by +18.69%.
Stock split effective on 18 Jan 2023
Shares were split 1 : 7 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Dec 2022
EPS came in at -$80.12 .
Earnings released on 30 Sept 2022
EPS came in at $378.17 surpassing the estimated -$421.40 by +189.74%.
Stock split effective on 26 Aug 2022
Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Jun 2022
EPS came in at -$1.04k surpassing the estimated -$2.10k by +50.40%.
Earnings released on 31 Mar 2022
EPS came in at -$2.60k .
Earnings released on 31 Dec 2021
EPS came in at -$3.16k .
Earnings released on 30 Sept 2021
EPS came in at -$13.67k .
Stock split effective on 13 Sept 2021
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
GRDX Stock Performance
Access detailed GRDX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
